Oramed Receives Patent Allowance in Israel, Australia for Platform Technology in Oral Delivery of Proteins
Oramed Pharmaceuticals . (NASDAQ: ORMP) announced today that it has received Notices of Allowance from the Israel and Australian Patent Offices. The patent entitled, "Methods and Compositions for Oral Administrations of Proteins" covers a core concept of the company's technology for the oral delivery of drugs and vaccines currently delivered via injection. The allowance in Israel marks the second from the Israel Patent Office in the past 30 days. Additionally, this is Oramed's second Australian patent allowance, following the grant of a different patent in May 2012. The patent has also been approved in Japan, China, Russia, and New Zealand.